AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2012
Apr 27, 2012
33422_dirs_2012-04-26_f5705a9a-a3e4-4d18-ab7d-76e99e079f48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2012-04-25
Reporting Person: PRESSLER HERMAN PAUL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-25 | Common Stock | P | 5000 | $3.103 | Acquired | 9500 | Direct |
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21